Saphner, Thomas J |
Aurora Health Care, Inc.
United States |
Aurora NCORP Community Site |
5UG1CA190140-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Sariol, Carlos A |
University Of Puerto Rico Med Sciences
United States |
SARS-CoV-2 correlates of protection in a Latino-origin population |
3U01CA260541-02S1 |
|
Guillermo Marquez, Ph.D. |
Schallenkamp, John M. |
Montana Cancer Consortium
United States |
Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming |
5UG1CA189872-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Schedin, Pepper J |
Oregon Health & Science University
United States |
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention |
5R01CA169175-11 |
|
|
Schloss, Patrick David |
University Of Michigan At Ann Arbor
United States |
muMS2: an open source R package for analyzing and integrating multi-omics datasets to improve early detection and understanding of colorectal cancer |
5U01CA264071-02 |
RFA-CA-21-014 (U01 Clinical Trial Optional) |
|
Schmidt, Christian Maximillian |
Indiana Univ-Purdue Univ At Indianapolis
United States |
Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer |
5U01CA239522-04 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
|
Schmit, Stephanie L |
Cleveland Clinic Lerner Com-Cwru
United States |
Variation in tumor-associated immune profiles and colorectal cancer outcomes |
5R01CA248931-03 |
|
|
Schoen, Robert E. |
University Of Pittsburgh At Pittsburgh
United States |
Blood-Based Testing for Advanced Adenoma |
5U01CA271884-02 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
|
Schroeck, Florian R |
Veterans Education/Res/Assn/North/Ne
United States |
Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance |
1R37CA275916-01 |
|
Claire Zhu, Ph.D. |
Sears, Rosalie C |
Oregon Health & Science University
United States |
Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs |
1U01CA278923-01 |
|
Matthew Young, Ph.D. |